Lon is a conserved AAA+ (ATPases associated with diverse cellular activities) proteolytic machine that plays a key regulatory role in cells under proteotoxic stress. Lon-mediated proteolysis can be stimulated by either the unfolded or specific protein substrates accumulated under stress conditions. However, the molecular basis for this substrate-controlled proteolysis remains unclear. Here, we have found that the heat shock protein LarA, a recently discovered Lon substrate and allosteric activator, binds to the N-terminal domain (NTD) of Lon. The crystal structure of the LarA-NTD complex shows that LarA binds to a highly conserved groove in the NTD through the terminal aromatic residue of its C-terminal degron. Crystallographic and biochemical evidence further reveals that this binding exposes the hydrophobic core of LarA, which can bind a leucine residue and promote local protein unfolding. These results define the mechanistic role of the NTD in regulating Lon-mediated proteolysis in response to varying cellular conditions.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11882793 | PMC |
http://dx.doi.org/10.1038/s41467-025-57482-6 | DOI Listing |
Am J Drug Alcohol Abuse
March 2025
Department of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV, USA.
Females remain underrepresented in opioid use disorder (OUD) research, particularly regarding dorsal striatal neuroadaptations. Chaperonins seem to play a role in opioid-induced neural plasticity, yet their contribution to OUD-related changes in the dorsal striatum (DS) remains poorly understood. Given known sex differences in opioid sensitivity, it is important to determine how chaperonin expression contributes to OUD-related adaptations in females.
View Article and Find Full Text PDFTrop Anim Health Prod
March 2025
Centre for Climate Resilient Animal Adaptation Studies, ICAR-National Institute of Animal Nutrition and Physiology, Adugodi, Bangalore, 560030, India.
An investigation was conducted to assess the efficacy of a novel antioxidant supplementation, Transcare, in alleviating transportation-induced stress among Bannur sheep. Thirty female Bannur sheep of 10-12 months, were selected and randomly assigned to two groups: Bannur Non-supplemented (BNS) (n = 15) and Bannur Supplemented (BS) (n = 15). The BS was supplemented with antioxidant powder (Transcare) orally at a dose of 10 g/animal, dissolved in 10 mL drinking water, 45-60 min preload.
View Article and Find Full Text PDFEndokrynol Pol
March 2025
Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, China.
Introduction: Thiamine-responsive megaloblastic anaemia syndrome (TRMA) is a rare genetic disease caused by mutations in the SLC19A2 gene that encodes thiamine transporter 1 (THTR-1). The common manifestations are diabetes, anaemia, and deafness. The pathogenic mechanism has not yet been clarified.
View Article and Find Full Text PDFJ Appl Toxicol
March 2025
Department of Zoology, Visva-Bharati, Santiniketan, West Bengal, India.
The extensive industrial use of lead (Pb) and chromium (Cr) has led to their persistent release into aquatic ecosystems, posing severe ecological and toxicological challenges. While the individual toxicities of these metals are well-documented, their combined effects, particularly on toxicity mechanisms and cellular stress responses, remain inadequately understood. This study investigated the hepatotoxic effects of Pb and Cr, both individually and in combination, in zebrafish (Danio rerio), focusing on oxidative stress and the Nrf2-Keap1-ARE signaling pathway.
View Article and Find Full Text PDFJ Cell Mol Med
March 2025
Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, P.R. China.
Cardiac remodelling, a pathological process induced by various cardiovascular diseases, remains a significant challenge in clinical practice. Here, we investigate the potential of Danuglipron (PF-06882961, PF), a novel oral glucagon-like peptide-1 (GLP-1) receptor agonist, in alleviating pressure overload (PO)-induced cardiac hypertrophy and fibrosis. Using both in vivo and in vitro models, we demonstrate that PF treatment (1 mg/kg/day, orally for 8 weeks) significantly attenuates aortic banding-induced cardiac dysfunction and pathological remodelling in mice.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!